recent articles
Aiforia obtained the In Vitro Diagnostic Regulation (IVDR) certification and successfully launches three new CE-IVD marked AI solutions for breast and prostate cancer diagnostics Aiforia Technologies Plc, Press Release, February 20, 2025 at...
Ibex: FDA clearance affirms Ibex’s position as a global leader in AI-powered cancer diagnostics February 10, 2025 08:05 AM Eastern Standard Time BOSTON--(BUSINESS WIRE)--Ibex Medical Analytics (Ibex), the leader in...
Aiforia selected to provide AI-assisted diagnostic solutions to regional health authorities in Italy Aiforia Technologies Plc PRESS RELEASE January 24, 2025 at 3.45 p.m. EET The Lombardy region health authorities in Italy have selected...
Deep Bio: Integrating Deep Bio's DeepDx Prostate Algorithm into PathAI's AISight IMS Platform SEOUL, SOUTH KOREA, November 19, 2024 /EINPresswire.com/ -- Deep Bio, a leader in artificial intelligence for digital pathology, announced a...
AP-HP has selected Aiforia as a partner for AI-assisted pathology i...
- Anatomic Pathology
- Artificial Intelligence
- Clinical Laboratories
- Cloud Computing
- Current Affairs
- Data Management
- Digital Pathology News
- Education
- Government
- Image Analysis
- Informatics
- International
- Laboratory Informatics
- Medical Research
- New Digital Imaging Technologies
- Pathology News
- Press Release
- Training
- Vendor products
- Web/Tech
- Whole slide
Assistance Publique–Hôpitaux de Paris (AP-HP) has selected Aiforia Technologies Plc as a partner for AI-assisted pathology image analysis in clinical diagnostics. The collaboration involves the use of the Aiforia Clinical AI solutions for...
SEOUL, SOUTH KOREA, August 6, 2024 /EINPresswire.com/ -- Deep Bio Inc., a leader in AI-driven digital pathology solutions, announced the publication of an external validation study for its DeepDx Prostate AI algorithm, conducted by Stanford...
